For the position of lincRNA-BC2, Dhillon et al. indicated that chr5q33 as a fragile site may be the unstable sites in the genome and can be used as suitable and reliable markers for genetic factor to breast cancer, epithelial ovarian cancer, and in non-small-cell lung cancer [20]. The gene discussed is CHMP2A; the disease is breast cancer.